Nontargeted Metabolomic Profiling of Huo-Tan-Chu-Shi Decoction in the Treatment of Coronary Heart Disease with Phlegm-damp Syndrome

Table 3

Comparison of LVPW and IVS measured by echocardiography (mean ± S.D, n = 5–6).

	IVSD (mm)	IVSS (mm)	LVPWD (mm)	LVPWS (mm)
Control	0.88 ± 0.24	1.35 ± 0.34	1.14 ± 0.30	1.50 ± 0.29
Tanshi	1.20 ± 0.10	2.08 ± 0.35	1.68 ± 0.24	2.03 ± 0.44
HTCSD	0.91 ± 0.26^#	1.83 ± 0.17	1.28 ± 0.27^#	1.51 ± 0.33^#

Note:p-value<0.05 (Tanshi vs Control), -value<0.01 (Tanshi vs Control), and ^#-value<0.05 (HTCSD vs Tanshi). IVSD: interventricular septal thickness at diastole, IVSS: interventricular septal thickness at systole, LVPWD: left ventricular posterior wall thickness at diastole, LVPWS: left ventricular posterior wall thickness at systole, ECG: electrocardiogram, HTCSD: Huo-Tan-Chu-Shi decoction.